Articles

Elsevier,

IBRO Neuroscience Reports, Volume 16, June 2024

This article summarizes current biomarkers, available treatments, and future therapeutic approaches for Alzheimer's disease, discussing drug targets like Amyloid β, Tau Protein, and various other mechanisms. Additionally, it highlights the historical use of Estradiol, outcomes of trials with antioxidants and omega-3 fatty acids, and ongoing clinical trials, providing a comprehensive overview of the evolving landscape in AD research and treatment.
Elsevier,

Journal of Neuroscience Methods, Volume 406, June 2024

This study presents an optimized method for isolating specific neuronal and glial cell populations and extracellular vesicles (EVs) from postmortem Alzheimer's disease (AD) cortical samples, demonstrating the feasibility of using a single cryopreserved brain sample to obtain RNA-seq and protein-level data, thereby enhancing understanding of neuron/glial interactions and disease progression.
Elsevier,

Brain Research, Volume 1832, June 2024

Recent research on Alzheimer's disease (AD) suggests that microglia, immune cells in the brain, may play a beneficial role in early disease stages but become harmful in later stages due to various spatial, temporal, and transcriptional factors. Understanding the phenotypic heterogeneity and multiple states of microglia could lead to advancements in personalized medicine and improved treatment outcomes for AD patients.
Elsevier,

Nexus, Volume 1, Issue 3, September 2024

Until now, the absence of data on global building floorspace has impeded the measurement of building carbon intensity (carbon emissions per floorspace) and the identification of ways to achieve carbon neutrality for buildings. For this study, we develop a global building stock model (GLOBUS) to fill that data gap.

Elsevier,

eClinicalMedicine, Volume 72, June 2024

This Article supports SDG3 by evaluating sex and gender disparities in terms of risk factors, treatment uptake/completion, and virological outcomes for hepatitis C, finding differences between men and women in, for example, exposure to different risk factors and likelihood of commencing treatment. More attention is needed in research to these disparities and how they could be addressed
Elsevier,

Quaternary Environments and Humans, Volume 2, Issue 3, June 2024, 100012

The study demonstrates that natural levee evolution in the central Kanto Plain is controlled by river migration and sea-level fluctuations, which are influenced by climate change, providing insights that can inform climate action.

Elsevier,

The Lancet Oncology, Volume 25, June 2024

This article links to the United Nations Sustainable Development Goals (SDGs) by addressing Goal 3 (Good Health and Well-Being) and Goal 13 (Climate Action), as it highlights the significant greenhouse gas emissions associated with radiotherapy, a critical component of cancer treatment. By proposing strategies to reduce the environmental impact of oncology care through sustainable practices and treatment modifications, the study emphasizes the importance of integrating health care with climate action efforts to promote both patient well-being and environmental sustainability.
Elsevier,

iScience, Volume 27, 21 June 2024

This study is a comprehensive assessment of the effects of climate change mitigation and pollution policies in China, providing policy recommendations.
Elsevier,

Quaternary Science Advances, Volume 14, June 2024

The primary outcome of our work is the strong evidence that flood hazards are related to the structural setting of the basin, which includes topography and geology, while the transition of flood hazards into disasters is mainly because of unplanned urbanization.
Elsevier,

iScience, Volume 27, 21 June 2024

In this study, the authors find that warmer temperatures to reduce language complexity of politicians.

Pages